AEON Biopharma (AEON)

• Market cap: $24.8M
• 1 day: -0.67%
• 5 days: -0.16%
• 1 month: -7.7%
• 3 months: -11.86%
• 6 months: 22.3%
• Year to date: -11.86%
• 1 year: 64.82%
• 5 years: -99.86%
• 10 years: -99.86%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Employees: 5